*Refresh the page if the below document does not appear.
Pharma giant Sun Pharma received a nod from the SEC (Subject Expert Committee) under the CDSCO (Central Drug Standard Control Organization) for the manufacturing and marketing of the Progesterone Sustained Release (SR) tablets of 200,300,and 400mg strengths.
The Mumbai-based company did not disclose the amount involved in the acquisition and has agreed to retain the site employees with no changes in the terms of employment. The manufacturing unit is spread across 47,597 metres and has approvals from EU, Health Canada, and Japanese Health Authority.
Chandigarh’s drug control department conducted tests for 10 drug samples out of which 50% failed to pass the test. More than 1.5 Lakh antibiotics were found to have no content of medicine and thousands of alcohol addiction treatment drugs were found to be spurious and substandard.
A preliminary report revealed the presence of multiple faults at the Maiden Pharma’s Sonepat facility. The people from state drug regulatory authority mentioned that details about the results were reported by the investigator to the union health minister on Tuesday.
The company’s stock has gained 10% over the past five sessions after getting four approvals from US FDA in a week. In a total, it has a whopping 326 approvals from 428 ANDAs (Abbreviated New Drug Applications) filed since June 30, 2022.
The IPO (Indian Patent Office) has granted a patent filed by NIPER (National Institute of Pharmaceutical Education and Research), Mohali for a new compound mentioned as an anti-tubercular agent along with an improved process of preparation for it which is beneficial to meet the imperfections of the existing drugs.
In allignment with the “Make in India”
programme, the Mumbai-based company
launched an integrated manufacturing unit for
single use bioprocessing solutions. The facility is
named ‘PharmNXT ekuse’ and has an area of
over 40,000 sq.ft.
If you don’t already have an account click the button below to create your account.Create New Account
Please update your profile to keep using the website